I still like the co
Almost no debt, growing revenue, generating cash flow, breaking into the US market.
Their approach to writing off R&D costs I believe is prudent even with the P&L volatility created.
If they generate a decent market share in the US this could rocket provided it is not at the cost of the current markets.
Share price, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
